Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
暂无分享，去创建一个
Y. Orba | H. Sawa | M. Sasaki | Haruaki Nobori | A. Sato | Shota Uehara | T. Sanaki | Teruhisa Kato | S. Ando | K. Uemura | Takahiro Suto | Y. Taoda | Y. Maruyama | Takafumi Sato | Shinsuke Toba | Yuki Tachibana | Yuto Unoh | T. Mizutare | Kenji Nakahara | A. Nakahashi | S. Yamamoto | Koji Kasamatsu | Shohei Kawashima | Y. Yamatsu | Kensuke Kouki